TrialPath
ALS (Lou Gehrig's disease) · Denver

ALS (Lou Gehrig's disease) clinical trials in Denver

1 recruiting amyotrophic lateral sclerosis studies within range of Denver. Click any trial for full eligibility criteria and contact info.

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)

NCT04363684 · Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP), Corticobasal Degeneration (CBD)
Recruiting

ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) represents the formalized integration of ARTFL (U54 NS092089; funded through 2019) and LEFFTDS (U01 AG045390; funded through 2019) as a single North American research consortium to study FTLD for 2019 and beyond.

Phase
TypeObservational
Age18 Years
WhereBirmingham, Alabama, United States + 26 more
SponsorMayo Clinic
Tap for details
Apply